{
  "retracted": false,
  "timestamp": 1569888000000,
  "updates": [
    {
      "timestamp": 1564715588498,
      "identifier": {
        "doi": "10.1016/j.canlet.2019.05.002"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.canlet.2019.03.052"
  },
  "journal": "Cancer Letters",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway” [Cancer Lett. 454 (2019) 179–190]"
}
